Cincinnati Business Courier: Queen City Angels-backed Alphyn eyes another fundraise amid ‘positive’ clinical study results
Cincinnati Business Courier: Queen City Angels-backed Alphyn eyes another fundraise amid ‘positive’ clinical study results by Liz Engel NEWS PROVIDED BY Alphyn Biologics January 11, 2023 Alphyn Biologics, a clinical-stage dermatology company developing a new class of drugs for skin diseases, will pursue a Series B financing round in 2023. Read the Cincinnati Business Courier…